FDA’s Top Ten GMP Inspection Findings for FY 2019

Drug Industry Daily
A A
With less than two weeks to go in fiscal 2019, an FDAnews analysis of the FDA’s GMP inspection reports for the year shows that drugmakers continue to stumble at the same old hurdles.

To View This Article:

Login

Subscribe To Drug Industry Daily